8 completed, 5 unknown, 1 not yet recruiting, 1 withdrawn. 15 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 15 | Completed 8, Unknown 5, Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 6 | Completed 2, Unknown 2, Not yet recruiting 1, Withdrawn 1 |
Follow Technical University of Munich: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) CD318-CAR-T cells - Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms | Phase 1 / Phase 2 | Not yet recruiting | University Hospital Tuebingen | 38 | 2026-07-01 | 2025-09-03 |
| Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication F/TAF, E/C/F/TAF, R/F/TAF - Insulin Resistance | Phase 1 | Completed | Technical University of Munich | 30 | 2017-04-18 | 2017-08-21 |
| Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer Afatinib 30Mg Tab, Afatinib 40Mg Tab, Gemzar - Metastatic Pancreatic Cancer | Phase 1 | Unknown | PD Dr. med. Volker Heinemann | 12 | 2016-09-01 | 2018-08-13 |
| Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum Secukinumab - Pyoderma Gangrenosum | Phase 1 / Phase 2 | Completed | Technical University of Munich | 8 | 2016-04-01 | 2023-04-12 |
| Improvement of Colonoscopy Preparation by New Media (APP) APP supported colonoscopy preparation - Gastrointestinal Neoplasms | Phase 1 | Unknown | Technical University of Munich | 25 | 2015-03-01 | 2015-07-30 |
| HER2-Peptide Vaccination of Patients With Solid Tumors Cyclophosphamide, Sargramostim, HER2-Peptid-Vakzine - Gastric Cancer, Breast Cancer | Phase 1 | Completed | Technical University of Munich | 2 | 2014-12-01 | 2019-11-20 |
| Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication Tenofovir disaproxil fumarate/emtricitabine/elvitegravir/cobicistat, Tenofovir disaproxil fumarate/emtricitabine + Lopinavir/ritonavir, Tenofovir disaproxil fumarate/emtricitabine + ritonavir-boosted darunavir - Insulin Resistance | Phase 1 | Completed | Technical University of Munich | 30 | 2014-07-01 | 2014-11-05 |
| The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon Wobenzym plus, PL 1 - Inflammation, Death, Sudden, Cardiac | Phase 1 | Completed | Technical University of Munich | 160 | 2013-08-01 | 2015-06-30 |
| Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation FBTA05 - Leukemia, Stem Cell Transplantation | Phase 1 / Phase 2 | Withdrawn | Technical University of Munich | 2010-08-01 | 2022-12-07 | |
| Endoscopic Resection of Gastric Subepithelial Masses, EndoResect Study Endoscopic resection - Gastric Subepitelial Mass | Phase 1 | Completed | Technical University of Munich | 38 | 2010-04-01 | 2012-04-24 |
| Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM) Umbilical Cord Blood VITA 34 - Type 1 Diabetes, Children | Phase 1 | Unknown | Technical University of Munich | 18 | 2008-09-01 | 2013-07-23 |
| Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia NILOTINIB, EVEROLIMUS - Acute Myeloid Leukemia | Phase 1 / Phase 2 | Completed | Technical University of Munich | 40 | 2007-12-01 | 2012-08-08 |
| Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer capecitabine, cisplatin, imatinib mesylate - Gastric Cancer | Phase 1 | Completed | Technical University of Munich | 38 | 2007-11-01 | 2013-03-19 |
| Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer cetuximab, fluorouracil, oxaliplatin - Esophageal Cancer | Phase 1 / Phase 2 | Unknown | Technical University of Munich | 43 | 2006-07-01 | 2014-05-01 |
| Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma rituximab, cyclophosphamide, fludarabine phosphate - Lymphoma | Phase 1 / Phase 2 | Unknown | Technical University of Munich | 12 | 2005-06-01 | 2012-08-28 |
Insulin Resistance (2) · Pancreatic Neoplasms (2) · Stomach Neoplasms (2) · Blood Coagulation Disorders (1) · Breast Neoplasms (1) · Carcinoma, Pancreatic Ductal (1) · Cardiovascular Diseases (1) · Death (1) · Death, Sudden (1) · Death, Sudden, Cardiac (1) · Diabetes Mellitus, Type 1 (1) · Esophageal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Gastrointestinal Neoplasms (1) · Heart Diseases (1)
Cyclophosphamide (2) · Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2) · 130-nm albumin-bound paclitaxel (1) · Afatinib (1) · Albumin-Bound Paclitaxel (1) · Bi20 antibody (1) · Capecitabine (1) · Cetuximab (1) · Cisplatin (1) · Emtricitabine (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Endoscopic Mucosal Resection (1) · Everolimus (1) · Fluorouracil (1) · Gemcitabine (1)
Germany (14)
Alexander Meining, MD (1) · Angela Krackhardt, Prof.Dr.med. (1) · Benjamin M Walter, MD (1) · Christian Peschel, MD (1) · Christoph D Spinner, MD (1) · Dirk Wilhelm, MD (1) · Florian Lordick, MD (1) · Johannes Scherr, Dr. med. (1) · Justus Prof. Duyster, MD (1) · Kilian Eyerich, MD, PhD (1) · Matthias Ebert, MD (1) · Stefan von Delius, MD (1) · Volker Heinemann, Professor (1)
PMID 23228190, PMID 23815981, PMID 24559067, PMID 26093876, PMID 28931498, PMID 29370708, PMID 34515338
2014 (1), 2015 (1), 2025 (1)